Express News | Emergent BioSolutions Inc - Cyfendus Vaccine Deliveries Expected to Complete by April 2025

Breakings21:00

Express News | Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted)

Breakings21:00

Investors Don't See Light At End Of Emergent BioSolutions Inc.'s (NYSE:EBS) Tunnel And Push Stock Down 26%

Simply Wall StDec 10 18:20

Emergent BioSolutions Inc.'s (NYSE:EBS) Institutional Investors Lost 11% Last Week but Have Benefitted From Longer-term Gains

Simply Wall StDec 8 20:41

WHO Extends Mpox Emergency; Canada Reports First Clade I Case

Seeking AlphaNov 24 03:48

World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern

BenzingaNov 23 01:43